Filed: 5/15/2025ACC: 0001012975-25-000245
📋 What this filing means
ARCH VENTURE MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 9 equity positions with a total reported market value of $206.22M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
9
Positions
$206.22M
Total AUM (reported)
34.86M
Total Shares
Allocation by class
COM$205.16M99.5%
COM NEW$1.06M0.5%
Portfolio Concentration
Top 3$171.58M83.2%
4–10$34.64M16.8%
Top 3 weight
83.2%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 34.86M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
34.86M
shares
% of voting shares100.0%
Investment Discretion (by position count)
Sole9
Shared0
Other0
Dominant voting typeNone · 100.0% of voting shares
Institutional Holdings9
Rows:
BEAM THERAPEUTICS INC.
SOLEShares4.54M
TypeSH
Market value$88.67M
43.00%
Sole
0.00
Shared
0.00
None
4.54M
MAZE THERAPEUTICS, INC.
SOLEShares4.12M
TypeSH
Market value$45.36M
22.00%
Sole
0.00
Shared
0.00
None
4.12M
RAPPORT THERAPEUTICS, INC.
SOLEShares3.73M
TypeSH
Market value$37.55M
18.21%
Sole
0.00
Shared
0.00
None
3.73M
ERASCA, INC.
SOLEShares11.06M
TypeSH
Market value$15.15M
7.34%
Sole
0.00
Shared
0.00
None
11.06M
VERVE THERAPEUTICS, INC.
SOLEShares2.01M
TypeSH
Market value$9.12M
4.42%
Sole
0.00
Shared
0.00
None
2.01M
GOSSAMER BIO, INC.
SOLEShares8.06M
TypeSH
Market value$8.78M
4.26%
Sole
0.00
Shared
0.00
None
8.06M
UNITY BIOTECHNOLOGY, INC.
SOLEShares1M
TypeSH
Market value$1.05M
0.51%
Sole
0.00
Shared
0.00
None
1M
Q32 BIO INC.
SOLEShares320.48K
TypeSH
Market value$532.0K
0.26%
Sole
0.00
Shared
0.00
None
320.48K
CERO THERAPEUTICS HOLDINGS, INC.
SOLEShares22.10K
TypeSH
Market value$16.1K
<0.01%
Sole
0.00
Shared
0.00
None
22.10K
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BEAM THERAPEUTICS INC.SOLE | COM | 4.54M | SH | $88.67M 43.00% | 0.00 | 0.00 | 4.54M |
MAZE THERAPEUTICS, INC.SOLE | COM | 4.12M | SH | $45.36M 22.00% | 0.00 | 0.00 | 4.12M |
RAPPORT THERAPEUTICS, INC.SOLE | COM | 3.73M | SH | $37.55M 18.21% | 0.00 | 0.00 | 3.73M |
ERASCA, INC.SOLE | COM | 11.06M | SH | $15.15M 7.34% | 0.00 | 0.00 | 11.06M |
VERVE THERAPEUTICS, INC.SOLE | COM | 2.01M | SH | $9.12M 4.42% | 0.00 | 0.00 | 2.01M |
GOSSAMER BIO, INC.SOLE | COM | 8.06M | SH | $8.78M 4.26% | 0.00 | 0.00 | 8.06M |
UNITY BIOTECHNOLOGY, INC.SOLE | COM NEW | 1M | SH | $1.05M 0.51% | 0.00 | 0.00 | 1M |
Q32 BIO INC.SOLE | COM | 320.48K | SH | $532.0K 0.26% | 0.00 | 0.00 | 320.48K |
CERO THERAPEUTICS HOLDINGS, INC.SOLE | COM NEW | 22.10K | SH | $16.1K <0.01% | 0.00 | 0.00 | 22.10K |